Loading company…
Synaura develops human milk oligosaccharides for food and nutrition products.
Founded in 2022, Synaura develops human milk oligosaccharides (HMOs) for infant formula, adult nutrition, and dairy products. The company is based in Shanghai, China, and is at the Series A stage. In May 2026, it raised Series A funding from Changkejin Investment.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in